Not Yet Recruiting PHASE1 INTERVENTIONAL 2-arm
NCT07110766
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ib Clinical Study to Evaluate the Efficacy and Safety of Small Molecule MDR-001 Tablets Administered Orally for 12 Weeks Treatment in Overweight or Obesity Participants
Sponsor: MindRank AI Ltd
Conditions
Obesity &Amp; Overweight
Updated 1 time since 2025 Last updated: Jul 31, 2025 Started: Aug 9, 2025 Primary completion: Sep 15, 2025 Completion: Oct 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Obesity &Amp; Overweight, this trial is actively recruiting participants. The trial is conducted by MindRank AI Ltd and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- MindRank AI Ltd
Data source: MindRank AI Ltd
For direct contact, visit the study record on ClinicalTrials.gov .